Clinical Trial Update: A Study Assessing the Efficacy and Safety of HS-10380 in Hospitalized Adults With Acute Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing the efficacy and safety of HS-10380 in hospitalized adults with acute schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• HS-10380

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: SCHIZOPHRENIA 1 (Disorder) | Phase 2 | Status: COMPLETED